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Abstract—Understanding the regulation of the apoptotic pro-
gram in neurons by intracellular pathways is currently a sub-
ject of great interest. Recent results suggest that c-Jun N-
terminal kinases (JNK), mitogen-activated protein kinases
and the transcription factor c-Jun are important regulators of
this cell death program in post-mitotic neurons following
survival-factor withdrawal. Our study demonstrates that cer-
amide levels increase upon survival-factor withdrawal in pri-
mary cultured cortical neurons. Furthermore, survival-factor
withdrawal or addition of exogenous c2-ceramide induces
JNK pathway activation in these cells. Western blot analyses
of JNK and c-Jun using phospho-specific antibodies reveal
that JNK and subsequent c-Jun phosphorylation occur hours
before the initiation of apoptosis, reflected morphologically
by neurite retraction and fragmentation, cell-body shrinkage
and chromatin fragmentation. Immunocytochemistry using
the same antibodies shows that phospho-JNK are localized
in the neurites of control neurons and translocate to the
nucleus where phospho-c-Jun concurrently appears upon
ceramide-induced apoptosis. To determine if ceramide-in-
duced c-Jun activation is responsible for the induction of the
apoptotic program, we performed transient transfections of a
dominant negative form of c-Jun, truncated in its transacti-
vation region. Our results show that DNc-Jun partially pro-
tects cortical neurons from ceramide-induced apoptosis.
Treatment of dominant negative c-Jun-expressing neurons
with the pharmacological inhibitor of p38 kinase, SB203580,
completely blocked neuronal death. Thus our data show that
p38 and JNK/c-Jun pathways cooperate to induce neuronal
apoptosis. © 2003 IBRO. Published by Elsevier Science Ltd.
All rights reserved.
Key words: primary cultures, SAPK, serum withdrawal, neu-
ronal death.
Many recent studies have sought to identify the key com-
ponents of the cell-death machinery in neurons and to
understand how the cell-death program is regulated by
intracellular signaling pathways activated by death factors,
binding to specific cell-surface receptors. Recent results
suggest that mitogen-activated protein kinase (MAP), c-
Jun N-terminal kinases (JNK) and p38 are important reg-
ulators of the cell death program in post-mitotic neurons
following survival-factor withdrawal (Mielke and Herdegen,
2000). Experiments with sympathetic neurons cultured in
vitro, as well as with cerebellar granule neurons and dif-
ferentiated pheochromocytoma 12 (PC12) cells, have
demonstrated that JNK/c-Jun and p38 signaling can pro-
mote apoptosis following survival-factor withdrawal. Over-
expression of dominant negative components of the JNK
or the p38 pathway reverses apoptosis induced by trophic-
factor withdrawal in PC12 cells (Xia et al., 1995).
One major target of the JNK pathway is the transcrip-
tion factor c-Jun, which is regulated at both transcriptional
and post-transcriptional levels by activated JNK (Davis,
2000). C-Jun may play a role in a wide variety of phenom-
ena including survival, differentiation, and neuronal regen-
eration (Herdegen et al., 1997). Recent evidence, wherein
blocking c-Jun function has protected neurons from apo-
ptosis, both in vitro (Estus et al., 1994; Ham et al., 1995)
and in vivo (Behrens et al., 1999; Crocker et al., 2001), has
specifically implicated c-Jun in apoptosis.
Recent studies in cultured cortical neurons have dem-
onstrated that increased ceramide levels, a second mes-
senger generated intracellularly by the sphingomyelinase-
mediated cleavage of sphingomyelin, activate MAP kinase
JNK and p38, subsequent to induction of apoptosis (Wil-
laime et al., 2001). Ceramide generation has been re-
ported as a mechanism for induction of apoptosis in re-
sponse to a variety of lethal agents such as tumor necrosis
factor, Fas-ligand, ionizing radiation, ultraviolet-C, heat
shock, oxidative stress and growth factor withdrawal in
non-neuronal cells (Mathias et al., 1998). Its implication in
apoptotic processes is strongly supported by experiments
on lymphoblasts from Niemann-Pick patients expressing
inactive sphingomyelinase or cultured fibroblasts from acid
sphingomyelinase knockout mice. In both situations cells
failed to respond to ionizing radiation-induced apoptosis
(Santana et al., 1996; Lozano et al., 2001). These defects,
as well as ceramide production, can be reversed when
acid sphingomyelinase activity is restored, suggesting that
ceramide is a central molecule in the apoptotic machinery.
Previous studies using in vivo and in vitro models of
neuronal death also implicate ceramide in the apoptotic
process. Firstly, sphingomyelinase activity is strongly in-
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creased during developmental neuronal death in rat brain
(Spence and Burgess, 1978). Secondly, increased cer-
amide levels are observed during apoptosis induced by
growth factor withdrawal in PC12 cells (Lambeng et al.,
1999) and after lethal ischemia in the gerbil hippocampus
(Nakane et al., 2000). Furthermore, apoptosis can be in-
duced by exogenous ceramide treatment of PC12 cells
(France-Lanord et al., 1997; Hartfield et al., 1997), mes-
encephalic (Brugg et al., 1996), hippocampal (Mitoma et
al., 1998) or cortical neurons (Willaime et al., 2001).
The objective of this study was to evaluate the role of
the signaling cascade downstream ceramide after survival-
factor withdrawal in cortical neurons. Using a dominant
negative transfection approach in combination with a phar-
macological inhibitor, we analyze herein the contribution of
JNK/c-Jun and p38 pathways in ceramide-induced neuro-
nal cell death.
EXPERIMENTAL PROCEDURES
Materials
C2-ceramide (N-acetylsphingosine, Biomol Research Laboratory,
Plymouth Meeting, PA, USA) was prepared as a 25 mM stock in
ethanol and incubated in the culture media as described. The
specificity of c2-ceramide was evaluated by comparing its effects
with those of c2-dihydro-ceramide (Biomol Research Laboratory,
Plymouth Meeting, PA, USA), an analog lacking the 4–5 trans
double bond in the sphingosine moiety of c2-ceramide, which has
been shown to be incapable of activating the sphingomyelin path-
way in lymphocytes (Bielawska et al., 1993; Obeid et al., 1993)
and neurons (Brugg et al., 1996).
Primary cultures of mouse cortex
Embryos were removed at day 14 from timed-pregnant Swiss
mice (Janvier, Le Genest-St-Isle, France). The cortex was dis-
sected, mechanically dissociated and plated on polyethyleneimine
(1 mg/ml) coated culture wells, in Eagle’s basal medium (Eurobio,
Les Ulis, France), supplemented with 5% horse serum (HS; Eu-
robio) and 2.5% fetal calf serum (FCS; Eurobio), at a density of
7.105 cells/cm2. After 2 days in culture the media was replaced
with N5 medium (Kawamoto and Barrett, 1986) with 180mg/l
glucose and changed daily; FCS content was reduced to 1%;
Ara-C (cytosine arabinoside, 3 M, Sigma, Saint Louis, MO, USA)
was added to prevent astrocyte proliferation (our cultures were at
least 95% neuronal after this treatment), and MK-801 (1 M,
Research Biochemicals International, Natick, MA, USA) to prevent
excitotoxicity (Knusel et al., 1990; Brugg et al., 1996). All experi-
ments conformed to French and international guidelines on the
ethical use of animals. We minimized the number of animals used
and their suffering.
Serum deprivation
Cells were deprived in serum after 5 days of in vitro culture.
Culture medium N5 5% HS and 1% FCS, MK-801, Ara-C was
replaced by N5 without serum but with MK-801, after washing
cells three times in this last medium.
Lipid extraction and ceramide quantization
Cells were washed with phosphate-buffered saline (PBS) and
scraped. After spinning 5 min at 4 °C, cell pellets were resus-
pended in water and homogenized by brief sonication. Aliquots
were saved for protein quantification. Lipids were extracted and
ceramide was quantitated using Escherichia coli diacylglycerol
kinase and 32P--ATP (NEN, Boston, MA, USA) according to
previously published procedures (Van Veldhoven et al., 1992).
Lipids were then resolved by thin-layer chromatography; radioac-
tivity associated with ceramides was scraped and quantitated by
liquid-scintillation spectrometry.
Ceramide treatment
Embryonic cortical neurons cultivated in 5% HS and 1% FCS,
optimal conditions for their maturation and differentiation, were
insensitive to c2-ceramide treatment. That is why we reduced
serum content to 1% HS, 24 h before any ceramide treatment
(Brugg et al., 1996). Thus, the effects seen were not due to partial
serum deprivation but rather to specific treatment, since control
cells were in the same serum conditions during the same time as
the treated cells. The culture conditions (concentration and time
course) under which c2-ceramide provokes cell death were deter-
mined by a cell-viability test.
Cell viability
Cell viability was determined by counting viable cells after a 10-
min treatment with bisbenzimide (Hoechst; 0.8 g/ml), Triton
X-100 (0.005%) or with the 3(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assay (the conversion of the yellow
tetrazolium salt, MTT, to the purple formazan dye depends upon
the mitochondrial activity; Slater et al., 1963; Altman, 1976). The
MTT assay was performed on neurons in N5 medium 1% HS, with
MTT (0.5 mg/ml) for 2 h in a humidified atmosphere at 37 °C, 5%
CO2. The purple formazan salt was solubilized in 100 l of a
solution containing 0.1 M HCl in isopropanol. The spectrophoto-
metric absorbency of the samples was determined at a 560 nm
wavelength.
Transfections
Transient transfection of primary cortical cultures was performed
with LipofectAMINE 2000 (Invitrogen, Groningen, The Nether-
lands) as recommended by the manufacturer’s protocol. Cells
were transfected with 1 g of enhanced green fluorescent protein
(pEGFP-N3; Clontech, Cambridge, UK) alone or in the presence
of 5 g of the dominant negative c-Jun (DNc-Jun; Ham et al.,
1995) After 6 h, the cultures were rinsed with fresh medium.
Transfection efficacy was 3–5% of the cells. After treatments, the
cells were fixed as described below. Immunocytochemical analy-
sis of DNc-Jun expression was performed using a mouse mono-
clonal anti-flag M2 antibody (Sigma), and an anti-mouse Cy3
conjugated antibody (1:1000, Amersham, UK) with the protocol
described below for P-JNK and P-c-Jun immunodetection.
Immunocytochemistry
After c2-ceramide treatment, cells were fixed in the super cells
cultured dishes with PBS containing 4% paraformaldehyde for 20
min and then incubated with methanol/acetone solution (50/50) for
10 min at 4 °C. Then, after washing three times with PBS, plates
were treated with blocking buffer containing FCS 10%, bovine
serum albumin (BSA) 1% in PBS for 2 h. Polyclonal antibodies
raised against dually phosphorylated SAPK/JNK (Thr183-
Tyr185JNK) (P-JNK, 1:500, New England Biolabs, Ozyme, France)
or Phospho-c-Jun (Ser73c-Jun) (P-c-Jun, 1:500, New England
Biolabs) were incubated overnight at 4 °C in PBS containing 1%
BSA, 0.05% Tween 20. Plates were rinsed in PBS and incubated
with an anti-rabbit fluorescein isothiocyanate-conjugated antibody
(1:750, Amersham) for 2 h. After counterstaining with propidium
iodide, cells were mounted under coverslips using vectashield
(Vector Abcys, France).
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Subcellular fractionation
Neurons were cultured in six-well plates, placed on ice, and lysed
in buffer containing Tris-EDTA 1 mM, NaCl 50 mM, NaPPi
330 mM, Triton X-100 10%, NaF 1 M and a mix of protease and
phosphatase inhibitors (100 M Na3VO4, 1 mM dithiothreitol,
100 nM okadaic acid, 2.5 g/ml aprotinin, 2.5 g/ml pepstatin,
0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM benzamidine,
0.5 g/ml leupeptin). Cells were homogenized with a dounce A
and then centrifugated (for 10 min at 1000g at 4 °C). The su-
pernatant corresponding to the cytosolic fraction was removed.
Then pellets corresponding to the nuclear fraction were washed
twice with lysis buffer. Protein extracts (10 g from each fraction)
were separated by 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) before electrotransfer. Blots
were blocked with 5% nonfat milk and incubated with rabbit poly-
clonal antisera raised against JNK (1:1000, New England Biolabs)
or Egr-1 (1:500; Santa Cruz, Santa Cruz, CA, USA) overnight at
4 °C. After rinsing, the blots were incubated with goat horseradish
peroxidase-conjugated antibody (1:2500) for 2 h at room temper-
ature before exposure to the ECL kit (Amersham).
Western blot analysis
Cultured neurons were lysed in solubilization buffer (10 mM
Tris–HCl, 50 mM NaCl, 1% Triton X-100, 30 mM Na4P2O7,
50 mM NaF, 5 M ZnCl2, 100 M Na3VO4, 1 mM dithiothreitol,
5 nM okadaic acid, 2.5 g/ml aprotinin, 3.6 M pepstatin,
0.5 M phenylmethylsulfonyl fluoride, 0.5 mM benzamidine,
5.3 M leupeptin) at 4 °C. Insoluble material was removed by
centrifugation (10,000g for 30 min at 4 °C) and samples were
stored at 80 °C. The proteins were dosed with the DC protein
assay kit (Bio-Rad, Hercules, CA, USA). Cell extracts contain-
ing equivalent amounts of protein were boiled for 5 min in
sample loading buffer. After a 10% SDS-PAGE, proteins were
transferred to a polyvinylidene difluoride membrane (ICN Bio-
chemicals, Costa Mesa, CA, USA). Non-specific sites were
blocked with 5% skimmed dried milk for 2 h. Blots were incu-
bated overnight at 4 °C with primary polyclonal antibodies
raised against dually phosphorylated SAPK/JNK (Thr183-
Tyr185JNK, P-JNK; 1:1000, New England Biolabs) or P-c-Jun
(Ser73c-Jun; 1:1000, New England Biolabs) in 5% BSA.
They were then incubated with horseradish peroxidase-
conjugated secondary rabbit polyclonal antibody (1:2500) in 5%
skimmed dried milk for 1 h. The revelation was processed with
enhanced chemiluminescence substrate (Amersham). The
blots were stripped with 0.1 M glycine–HCl (pH 2.8) twice for 30
min at 60 °C and SDS 2% for 10 min, followed by saturation in
5% skimmed dried milk overnight at 4 °C. They were then
incubated with the primary antibodies (New England Biolabs)
raised against synthetic peptides specific for JNK diluted
1:1000 detecting both phosphorylated and non-phosphorylated
forms of JNK, in 5% skimmed dried milk. They were incubated
with a horseradish peroxidase-conjugated secondary antibody
(1:2500) in 5% skimmed dried milk for 1 h. The revelation was
processed as described above. Quantification was processed
using the Densylab software (Microvision Instruments, Evry,
France).
RESULTS
Serum withdrawal-induced neuronal apoptosis
increases ceramide levels in cortical neurons
Cortical neurons were deprived of serum after a 5-day
maturation period in vitro and assayed for cell viability at
various time points after treatment using the MTT metab-
olism assay (Fig. 1A). No significant loss of viability was
detected during the first 6 h of treatment; however, after
this lag phase the neurons degenerated progressively.
After 24 and 42 h, 52% and 37% of the cells survived in the
culture respectively (Fig. 1A).
We measured ceramide levels, a stress and apoptotic
lipid second messenger, during serum withdrawal in cul-
tured cortical neurons. There was a biphasic increase in
ceramide levels: a rapid two-fold induction after 0.5 h that
then decreased and another 2.5-fold induction after a 16-h
serum withdrawal, compared with the control value (Fig.
1B). Thus, serum withdrawal-induced apoptosis in cortical
neurons induces ceramide levels increase in two distinct
waves.
Cortical neurons were treated after a 5-day maturation
period in vitro with c2-ceramide and assayed for cell via-
bility at various times after treatment using the MTT me-
tabolism assay (Fig. 1C). After a 24-h treatment, survival
was inversely correlated with c2-ceramide concentration in
the range between 10 and 75 M (Willaime et al., 2001). At
the concentration we used (40 M) no significant loss of
viability was detectable during the first 12 h of treatment;
after that the neurons degenerated progressively. After 24
and 48 h, 50% and 10% of the cells survived in the culture
respectively (Fig. 1C).
Serum withdrawal and ceramide use a common
apoptotic pathway including JNK phosphorylation
We have previously described JNK activation in ceram-
ide-induced apoptosis (Willaime et al., 2001) and here
we have analyzed JNK activation during serum with-
drawal in cortical neurons by Western blot. Three differ-
ent genes (JNK1, JNK2, JNK3) encode for the JNK
proteins, each in giving rise to alternatively spliced iso-
forms (Gupta et al., 1996) whose in vitro translation
produces two major proteins of 54 and 46 kD. JNKs are
activated by dual phosphorylation on residues Thr183
and Tyr185 (P-p54 and P-p46). Using an antibody specifi-
cally directed against active JNKs, we found that serum
withdrawal gradually increased P-p54 and P-p46 levels
throughout the 24 h of treatment (Fig. 2A, upper panel).
Using the same antibody, we found that c2-ceramide
(40 M) increased P-p54 and P-p46 levels (Fig. 2B, upper
panel), as previously described (Willaime et al., 2001).
These increases resulted from phosphorylation, as the
total JNK levels did not increase significantly during treat-
ment (Fig. 2A and 2B, lower panels). P-p46 level increased
more slowly with serum withdrawal than ceramide treat-
ment, and reached 250% of the control values after a 24-h
treatment under both conditions (Fig. 2C). Thus serum
withdrawal and ceramide treatment induced a strong acti-
vation of JNKs.
C2-ceramide induces P-JNK nuclear translocation
and subsequent c-Jun phosphorylation during
apoptosis of cortical neurons
As JNKs have a wide variety of potential phosphoryla-
tion substrates it is important to analyze the localization
of P-JNK within the cell to understand its possible ef-
fects upon nuclear transcription factors. Immunocyto-
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chemical detection of the phosphorylated and thereby
active form of JNKs (P-JNKs), was used and kinetics of
JNK activation were analyzed in this model system by
immunofluorescence (Fig. 3A). A low basal level of P-
JNK immunoreactivity was found in control cells that
corresponded, nevertheless, to an exclusive neuritic lo-
calization. After 8 h of c2-ceramide (40 M) treatment
and thereafter, P-JNK immunoreactivity showed a dis-
tinct localization in a vast majority of neurons, confirmed
by confocal microscopy analysis (Fig. 3A, insert). To
confirm this biochemically, we fractionated cortical ex-
tracts into the nucleus and the cytoplasm. As a control of
our fractionation procedure, Egr-1 immunoblotting was
performed and showed an immunoreactive band at 57
kD, the expected molecular weight for Egr-1, in the
nuclear extract almost exclusively. From these fractions,
we then analyzed the distribution of JNK by immunoblot-
ting. This shows a strong increase in nuclear JNK p46
isoform after ceramide treatment (Fig. 3B), correspond-
ing to the nuclear labeling of P-JNK found by immuno-
cytochemistry (Fig. 3A), with no translocation of JNK
p54 isoform. This result together with immunocytochem-
ical analyses of P-JNKs strongly support that p46 is the
major JNK isoform (see Fig. 2B) phosphorylated and
translocated upon ceramide treatment. Together these
data show that JNKs are activated and translocated into
the nucleus during ceramide treatment.
Within the nucleus, activated JNKs are known to
control the phosphorylation state of c-Jun as well as its
transcriptional control (Angel et al., 1988). By Western
blot using an antibody specific for the phosphorylated
form of c-Jun (P-c-Jun), we found that c2-ceramide in-
creased phosphorylation of c-Jun at 10 and 16 h of
ceramide treatment (Fig. 4A), compared with loading
control with the total JNKs that did not change during
ceramide treatment.
Next, we examined c-Jun phosphorylation by immuno-
cytochemistry with the same antibody (Fig. 4B). In contrast
to control neurons (t0), where we failed to detect any
P-c-Jun-immunoreactivity (green), P-c-Jun-immunoreac-
tivity appeared after 8 h of c2-ceramide (40 M) treatment
and strong levels persisted well after 16 h of treatment.
Thus, c-Jun phosphorylation appears with JNK activation
and translocation.
Overexpression of dominant negative c-Jun blocks
ceramide-induced apoptosis in primary cortical
neurons
To address the role of c-Jun activation in ceramide-in-
duced neuronal apoptosis, we overexpressed a dominant
negative form of c-Jun (DNc-Jun) in primary cortical neu-
rons. We used a construct corresponding to a deletion of
Fig. 1. (A) Serum withdrawal treatment induces neuronal death in
cultured cortical neurons. The effect is time-dependent. Survival was
assessed using the MTT assay. Data represent meanS.E.M.,
neight independent experiments. *P0.05 compared with the control
value, according to the one-way ANOVA followed by Dunnett’s post
hoc test. (B) Ceramide level increases during serum withdrawal-in-
duced neuronal death. Data represent meanS.E.M., nthree inde-
pendent experiments. *P0.05 compared with the control value, ac-
cording to the one-way ANOVA followed by Dunnett’s post hoc test.
(C) C2-ceramide treatment induces neuronal death in cultured cortical
neurons. The effect is time-dependent. Survival was assessed using
the MTT assay. Data represent meanS.E.M., nfour independent
experiments.
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the first 169 amino acids, the region containing the trans-
activation domain, which contains the phosphorylation tar-
get sites of activated JNK (Ham et al., 1995). Neurons
were transfected with GFP alone or in combination with
DNc-Jun. GFP expression allowed for visualization of the
cytoarchitecture, including neuritic extension of transfected
neurons and cell body (analyzed after 24 h of c2-ceramide
treatment) in transfected neurons. Immunocytochemical
detection of DNc-Jun showed its nuclear localization, as
well as coexpression with GFP in double-transfected neu-
rons (Fig. 5H). In control conditions, neurons transfected
with GFP alone (Fig. 5A, B) or in combination with DNc-
Fig. 2. Serum withdrawal (A) and c2-ceramide (B) induce an increase of JNK phosphorylation in cultured cortical neurons. Immunoblot analysis of
P-JNKs (P-p54 and P-p46, upper panels) and total JNKs (total p54 and total p46, lower panels) in extracts of treated cortical neurons. (C)
Quantification of P-p46 immunoreactivity in Western blot analyses during serum withdrawal or ceramide treatment. P-p46 signals were normalized to
the corresponding total p46 signal. Data represent meanS.E.M., n4 independent experiments. *P0.05 compared with the control value, according
to the one-way ANOVA followed by Dunnett’s post hoc test.
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Jun (Fig. 5G–I) showed very long neuritic extensions and
normal nuclei. After 24 h of c2-ceramide (40 M) treat-
ment, 48.7% of neurons transfected with GFP alone are
alive whereas the others exhibited a strong retraction and
fragmentation of neurites (Fig. 5C) and nuclear fragmen-
tation (Fig. 5D), quantified in Table 1. In contrast, 77.3% of
neurons coexpressing GFP and DNc-Jun and treated
for 24 h with ceramide were alive (Fig. 5E, F, Table 1), thus
demonstrating that activation of c-Jun plays an important
role in ceramide-induced neuronal apoptosis.
Treatment of DNc-Jun-expressing neurons with p38
inhibitor completely protects cortical neurons
against ceramide-induced apoptosis
We previously described that SB203580, a specific inhib-
itor of p38 pathway, also partially protects against ceram-
Fig. 3. (A) C2-ceramide induces a nuclear translocation of P-JNK in cultured cortical neurons. Neurons were untreated (t0) or c2-ceramide (40 M) treated
during indicated times. Neurons are immunostained for P-JNK (green) and nuclear labeled by propidium iodide (red) in cortical cultures. Nuclear localization
of P-JNK shows yellow labeling in these merge images (white arrows) and is confirmed by confocal microscopy insert at 8 h. Empty arrows: P-JNK labeling
in the dendrites; arrowheads: condensed and fragmented nuclei. Scale bar20 M. (B) Western blot analysis of JNK from subcellular fractionation of cortical
neurons. Specific labeling corresponding to the expected molecular weights for JNK was detected in cytosolic and nuclear compartment during ceramide
treatment. As a control of fractionation, Egr-1 immunoblotting was performed showing a specific nuclear immunostaining.
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ide-induced apoptosis (Willaime et al., 2001) in exactly the
same conditions as in this new study (Table 1). Here we
show that treatment of DNc-Jun-expressing neurons with
SB203580 completely protects cortical neurons against
ceramide (40 M)-induced apoptosis: neuronal survival is
96.9% of the control with double treatment, versus 77.3%
and 76.0% with DNc-Jun and SB203580 respectively (Ta-
ble 1).
DISCUSSION
Ceramide generation has been reported as a mechanism
for the induction of apoptosis in response to different stress
stimuli in a variety of non-neuronal cells types. The present
study demonstrates that the second-messenger ceramide
increases upon survival-factor withdrawal in primary corti-
cal neurons. Serum deprivation increased endogenous
ceramide levels in a two-peak manner: the first peak oc-
curred very rapidly within the first hour and the second
peak at 16 h after the apoptotic process had already been
engaged. These data, together with the previous findings
which demonstrate that a 6-h pulse of c2-ceramide treat-
ment is sufficient to commit neurons to die (Hunot et al.,
1997), suggest that the first ceramide peak could be re-
sponsible for apoptosis induction. This rapid and transient
increase of ceramide may reflect an activation of sphingo-
myelinases, as seen after stimulation of non-neuronal cells
with TNF-	, Il-1
 and Fas-ligand (for review see Kronke,
1997). The mechanism of receptor mediated sphingomy-
elinase activation after survival-factor withdrawal, how-
ever, remains unidentified.
Fig. 4. (A) Immunoblot analysis of P-c-Jun (upper panel) in extracts of ceramide-treated cortical neurons and loading control with total JNKs (total p54
and total p46, lower panel). (B) C2-ceramide induces an increase of P-c-Jun in the nuclei of cultured cortical neurons. Neurons immunostained for
P-c-Jun (green) and nuclear labeled by propidium iodide in cortical cultures. Neurons control (t0) or treated with c2-ceramide (40 M) during indicated
times. White arrows: normal nuclei; arrowheads: condensed and fragmented nuclei. Scale bar20 M.
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Fig. 5.
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The second ceramide peak could reflect an increase in
ceramide synthase activity, since it has been reported that
fumonisin B1, a ceramide synthase inhibitor, can decrease
this second peak (Jaffrezou et al., 1998). This might reveal
a cellular degeneration process since this late ceramide
production is also observed under necrotic conditions
(Bose et al., 1995; Jaffrezou et al., 1998). The implication
of the rapid ceramide peak in apoptosis induction is fur-
thermore supported by the finding that serum withdrawal or
c2-ceramide treatment induces an almost identical time
course of JNK phosphorylation (Fig. 2). Ceramide gener-
ation and JNK activation could also be correlated in vivo in
animal models of ischemia, as data show that ceramide
levels increase (Nakane et al., 2000) and JNK1 has been
shown to activate and translocate to the nuclei (Mizukami
et al., 1997).
To further evaluate JNK activation in neuronal apopto-
sis involving ceramide we have investigated JNK activation
by immunocytochemistry. To our knowledge this is the first
documentation showing that ceramide may induce nuclear
translocation of JNK in neurons. This event coincides with
the increase in JNK phosphorylation (Fig. 2) after 8 h of
ceramide treatment. JNK activation and nuclear transloca-
tion in neurons have been reported in vivo under different
pathological conditions. Nuclear localization of JNK has
been detected in degenerating neurons of Alzheimer pa-
tients (Zhu et al., 2001) and in cerebellar granule neurons
(Coffey et al., 2000, 2002). JNK1 and JNK3 translocation
from the cytosol to the nucleus in neurons can also be
observed in experimental models of hypoxia (Zhang et al.,
1998) and ischemia (Mizukami et al., 1997) respectively.
The mechanism by which ceramide activates the JNK
pathway in neurons, however, has yet to be identified.
Several intermediate kinases described in other cellular
systems may be involved in this process in neurons, in-
cluding the small G-protein Rac1 (Brenner et al., 1997), the
MAP kinase TGF
-activating kinase 1 (Schirakabe et al.,
1997); the MAP 3 kinase 1 (Takekawa et al., 1997) or the
apoptosis signal-regulated kinase 1 (Chen et al., 1999).
Further investigations will help to determine how ceramide
and serum withdrawal induce the JNK pathway in neurons.
JNK activation, and its nuclear translocation, has been
associated to transcriptional events that occur early in the
apoptotic process (Ham et al., 2000). Consistent with this,
we found an increase of the transcription factor c-Jun’s
phosphorylation in the neuronal nuclei after ceramide
treatment.
To further investigate the specific role of the JNK/c-Jun
pathway in ceramide-induced cortical neuron apoptosis,
we overexpressed a DNc-Jun in primary cortical neurons.
Our results demonstrate that DNc-Jun partially protects
cortical neurons against ceramide-induced apoptosis. This
is consistent with data obtained in others models, such as
PC12 cells (Xia et al., 1995; Lambeng et al., 2003) and
sympathetic neurons (Ham et al., 1995) deprived of NGF.
We previously described that SB203580, a specific
inhibitor of the p38 pathway, also partially protects against
ceramide-induced apoptosis (Willaime et al., 2001) in ex-
actly the same conditions as in the present study. The
cooperative role of p38 and JNK/c-Jun pathway remained
to be addressed. Although the result was previously sug-
gested in two articles, in each the specificity of pharmaco-
logical agents is contestable: Le Niculescu et al. used the
p38 inhibitor SB202190 at high unspecific doses to also
inhibit JNKs (Manthey et al., 1998; Le-Niculescu et al.,
1999); Namgung and Xia used CEP1347 as a JNK inhib-
itor in cooperation with a p38 inhibitor (Namgung and Xia,
2000), but CEP1347 has since been shown to affect mixed
lineage kinase family rather than directly JNKs (Maroney et
al., 2001). In this study we have employed an alternative
approach using p38 kinase inhibitor SB203580 and DNc-
Jun. We obtained a complete protection in our model. In
others models, where DNc-Jun alone almost completely
protects cells against apoptosis, p38 kinase is not acti-
vated during apoptosis (Watson et al., 1998) or not de-
scribed. Furthermore, Xia et al. showed that either DNc-
Table 1. c-Jun and p38 cooperate in ceramide-induced neuronal apoptosis
Transfection Treatment Survival of transfected neurons (percent of control)
GFP – 100.006.1
GFP cer 48.74.3
GFP cerSB 76.05.0*
GFPDNc-Jun – 100.07.7
GFPDNc-Jun cer 77.34.3*
GFPDNc-Jun cerSB 96.911.4*#£
A dominant negative form of c-Jun (DNc-Jun) protects neurons from apoptosis induced by c2-ceramide and treatment of DNc-Jun-expressing neurons
with SB203580 completely protects cortical neurons against ceramide-induced apoptosis. Primary cortical neurons were transfected with green
fluorescent protein (GFP) alone or in combination with DNc-Jun, treated with ceramide and/or SB203580, and transfected neurons having normal
nuclei were quantified. Data represent meanS.E.M. n15 wells from three independent experiments, P0.05 compared with GFPcer value (*),
with GFPcerSB value (#), or with GFPDNc-Juncer value (£), according to the one-way ANOVA followed by Student Newman-Keuls post hoc
test; cerc2-ceramide (40 M); SBSB203580 (10 M).
Fig. 5. A DNc-Jun protects neurons from apoptosis induced by c2-ceramide. Primary cortical neurons were transfected with GFP alone (A–D) or in
combination with a DNc-Jun (lacking the first 169 amino acids, E–I). Transfected neurons are visualized by GFP (A, C, E, G) and Hoechst (B, D, F,
I). Control (A, B, G–I) or ceramide treated (C–F) neurons. In cotransfected neurons, detection of DNc-Jun expression was performed using an antibody
that recognizes the FLAG epitope (H). White arrows: alive cells; empty arrows: dead cells. Scale bar20 M.
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Jun or dominant negative form of MKK3, upstream kinase
of p38s, protects completely PC12 cells from NGF with-
drawal-induced apoptosis. They did not explore the coop-
erative role of p38 and JNK/c-Jun pathway. Thus, our data
further demonstrate that p38 kinase and JNK/c-Jun act in
parallel to induce neuronal apoptosis by ceramide.
The pro-apoptotic action of p38 in ceramide-induced
apoptosis may be mediated by apoptotic effectors: Bax
translocation from the cytosol to the mitochondria is de-
pendent upon p38 (Ghatan et al., 2000); Bid is cleaved
upon p38 activation and leads to mitochondrial dysfunction
(Zhuang et al., 2000); Fas-ligand expression is regulated
by p38 and is pro-apoptotic (Zhang et al., 2000);
GADD153/CHOP activation is controlled by p38 and is
involved in ceramide-induced apoptosis (Brenner et al.,
1997). The pro-apoptotic action of JNK/c-Jun in ceramide-
induced apoptosis may be mediated by apoptotic effectors
such as Fas-ligand which expression is also regulated by
JNK (Herdegen et al., 1998; Morishima et al., 2001), since
the Fas-ligand promoter contains an AP-1 site that enables
the promoter to be activated by the JNK pathway. Bim, a
pro-apoptotic member of Bcl-2 family, which is strongly
induced in sympathetic neurons on NGF withdrawal, has
also been shown to be under the transcriptional control of
the JNK pathway (Putcha et al., 2001; Whitfield et al.,
2001).
Our results show that p38 kinase and JNK/c-Jun act in
parallel to induce neuronal apoptosis by ceramide. With
this double inhibition, we obtained a complete protection
against neuronal apoptosis. These results suggest that
multitherapy with specific inhibitors of these signaling path-
ways could have important synergistic effects for inhibiting
neuronal apoptosis.
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